|21.71||-0.34 / -1.54%|
As of 3:59pm ET
|21.71||+0.01 / +0.05%|
The 7 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 40.00, with a high estimate of 48.00 and a low estimate of 22.00. The median estimate represents a +84.25% increase from the last price of 21.71.
The current consensus among 8 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.